Autoimmune hemolytic anemia in a patient with primary ovarian non-Hodgkin's lymphoma

11Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The primary ovarian lymphoma is a rare disease with poor prognosis. The incidence of autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma is estimated at 3%. However, a substantial portion of the previously reported cases of ovarian lymphoma actually represented ovarian involvement by more diffuse lymphomatous process. If stringent criteria are used for case selection, true primary ovarian lymphoma usually carries a favorable prognosis. We present a primary malignant lymphoma of ovary accompanied by autoimmune hemolytic anemia in a 29-yr- old patient. After ablative surgery, the hemoglobin level and the reticulocyte count were normalized. One year following surgery and chemotherapy, the patient is alive and disease free.

Cite

CITATION STYLE

APA

Jung, C. K., Park, J. S., Lee, E. J., Kim, S. H., Kwon, H. C., Kim, J. S., … Kim, H. J. (2004). Autoimmune hemolytic anemia in a patient with primary ovarian non-Hodgkin’s lymphoma. Journal of Korean Medical Science, 19(2), 294–296. https://doi.org/10.3346/jkms.2004.19.2.294

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free